Using Artificial Intelligence to Reduce the Risk of Nonadherence in Patients on Anticoagulation Therapy
Stroke 48:1416-1419, Labovitz, D.L.,et al, 2017
Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Anticoagulant Patient Information Material Is Written at High Readability Levels
Stroke 31:2966-2970, Estrada,C.A.,et al, 2000
Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999
Long-Term Therapeutic Management of Epilepsy
Ann Int Med 120:411-422, French,J., 1994